Share Facebook Twitter LinkedIn Pinterest Email Audioeye projects Q2 2025 revenue growth with accelerating ARR
Sage Therapeutics outlines Q1 2025 growth in ZURZUVAE prescriptions and pipeline progress (NASDAQ:SAGE)April 30, 2025
AtriCure targets $517M-$527M revenue in 2025 with strong growth in appendage management and pain management (NASDAQ:ATRC)April 30, 2025